BIOMAT Database Logo BIOMAT Database Logo

[Myasthenia gravis induced by atezolizumab]. 2022

J García-García, and I Díaz-Maroto, and E González-Villar, and A Martínez-Martín
Complejo Hospitalario Universitario de Albacete, Albacete, España.

UI MeSH Term Description Entries
D009157 Myasthenia Gravis A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition. Anti-MuSK Myasthenia Gravis,MuSK MG,MuSK Myasthenia Gravis,Muscle-Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle-Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Generalized,Myasthenia Gravis, Ocular,Anti MuSK Myasthenia Gravis,Generalized Myasthenia Gravis,Muscle Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Anti-MuSK,Myasthenia Gravis, MuSK,Ocular Myasthenia Gravis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D061067 Antibodies, Monoclonal, Humanized Antibodies from non-human species whose protein sequences have been modified to make them nearly identical with human antibodies. If the constant region and part of the variable region are replaced, they are called humanized. If only the constant region is modified they are called chimeric. INN names for humanized antibodies end in -zumab. Antibodies, Humanized,Humanized Antibodies

Related Publications

J García-García, and I Díaz-Maroto, and E González-Villar, and A Martínez-Martín
De Novo Myasthenia Gravis Induced by Atezolizumab in a Patient with Urothelial Carcinoma.
June 2019, Cureus,
J García-García, and I Díaz-Maroto, and E González-Villar, and A Martínez-Martín
Myasthenia gravis induced by avelumab.
October 2019, Immunotherapy,
J García-García, and I Díaz-Maroto, and E González-Villar, and A Martínez-Martín
[Myasthenia gravis induced by D-penicillamine].
August 1983, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
J García-García, and I Díaz-Maroto, and E González-Villar, and A Martínez-Martín
[Penicillamine-induced myasthenia gravis].
September 1983, Deutsche medizinische Wochenschrift (1946),
J García-García, and I Díaz-Maroto, and E González-Villar, and A Martínez-Martín
[Penicillamine-induced myasthenia gravis].
January 2001, Ryoikibetsu shokogun shirizu,
J García-García, and I Díaz-Maroto, and E González-Villar, and A Martínez-Martín
Penicillamine-induced myasthenia gravis.
February 1984, Journal of the Mississippi State Medical Association,
J García-García, and I Díaz-Maroto, and E González-Villar, and A Martínez-Martín
Penicillamine-induced myasthenia gravis.
February 1979, Arthritis and rheumatism,
J García-García, and I Díaz-Maroto, and E González-Villar, and A Martínez-Martín
[Penicillamine induced myasthenia gravis].
July 1980, Ugeskrift for laeger,
J García-García, and I Díaz-Maroto, and E González-Villar, and A Martínez-Martín
Myasthenia gravis induced by alpha-interferon therapy.
August 1995, American journal of hematology,
J García-García, and I Díaz-Maroto, and E González-Villar, and A Martínez-Martín
Myasthenia gravis induced by autoantibodies against MuSK.
December 2007, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology,
Copied contents to your clipboard!